UPDATE: JP Morgan Initiates Tenet Healthcare at Overweight on Share Buyback, Reform Leverage
Posted on December 18, 2012 at 12:58 PM EST
JP Morgan initiated coverage on Tenet Healthcare (NYSE: THC ) with an Overweight rating and a $41 price target. JP Morgan noted, "While THC stock has performed well of late, we continue to see potential for upside given a combination of strong relative upside from reform in addition